Loading provider…
Loading provider…
Dermatology Physician in Santa Monica, CA
NPI: 1356477087Primary Practice Location
UCLA Dept of Dermatology
2020 Santa Monica Blvd, Santa Monica, CA
Primary Employer
UCLA Dept of Dermatology
uclahealth.org
HQ Phone
Get MD April's Phone Numberphone_androidMobile
Get MD April's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2008 - 2026
CO State Medical License
2013 - 2017
MA State Medical License
2004 - 2008
CA State Medical License

American Board of Dermatology
Dermatology

National Board of Medical Examiners
Diplomate
Harvard Medical School
hms.harvard.edu
Medical School
Until 2004
Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
Residency • Dermatology
2005 - 2008
Mass General Brigham/Massachusetts General Hospital
Internship • Internal Medicine
2004 - 2005
Harvard School of Public Health
—
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 84 | 105 |
| 2 | 17000Destruction of skin growth | 32 | 35 |
| 3 | 17003Destruction of 2-14 skin growths | 14 | 83 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 12 | 13 |
Report from the International Dermatology Outcome Measures Initiative.
Authors: Joseph Merola, Alice Gottlieb
Journal: J Investig Dermatol Symp Proc
Response to: “Is tonsillectomy a therapeutic option for plaque-type psoriasis?”
Authors: April W. Armstrong, Aleksandra G. Florek
Publication Date: 2015-10
Lead Sponsor: University of California, Davis
Intervention / Treatment: BEHAVIORAL: Virtual Counseling
Lead Sponsor: University of Pennsylvania
Collaborators: AbbVie
Intervention / Treatment: DRUG: Adalimumab
Lead Sponsor: University of Pennsylvania
Intervention / Treatment: DRUG: Placebo Injection, OTHER: NB-UVB phototherapy, DRUG: Adalimumab (Humira)